In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Bio-Rad buys Pasteur Sanofi Diagnostics for $210mm

Executive Summary

Bio-Rad Labs (manufactures/distributes life science research products, clinical diagnostics) has acquired Pasteur Sanofi Diagnostics, which is jointly owned by Sanofi-Synthelabo SA and the nonprofit Institut Pasteur. Bio-Rad gets 100% of PSD shares as well as certain assets for $210mm, and will assume some debt.
Deal Industry
  • In Vitro Diagnostics
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Cytology
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Cash

Related Companies